Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 4Neoplasm Metastasis 3Colorectal Neoplasms 3Breast Neoplasms 3Recurrence 2Head and Neck Neoplasms 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Thyroid Diseases 1Stomatitis 1Stomach Neoplasms 1Squamous Intraepithelial Lesions 1Smoking 1Rectal Neoplasms 1Prostatic Neoplasms 1Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polycystic Ovary Syndrome 1Papillomavirus Infections 1Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1Mucositis 1Mesothelioma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, B-Cell 1Laryngeal Diseases 1Infertility 1

Interventions

Vitamin B 12 1Folic Acid 1Erlotinib Hydrochloride 1Budesonide 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Smoking × Folic Acid × Clear all
NCT00606502 2021-03-05

Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment

Spectrum Pharmaceuticals, Inc

Phase 2 Completed
201 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡